SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-232774
Filing Date
2014-06-11
Accepted
2014-06-11 08:49:52
Documents
3
Period of Report
2014-06-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d738931d8k.htm 8-K 13738
2 EX-99.1 d738931dex991.htm EX-99.1 62481
3 GRAPHIC g738931g33j40.jpg GRAPHIC 2293
  Complete submission text file 0001193125-14-232774.txt   80840
Mailing Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803 617-513-9882
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 14903596
SIC: 2834 Pharmaceutical Preparations